Skip to main content

Table 2 Spirometry characteristics of study participants.

From: Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV

 

OLD-

OLD+

 
 

HIV-

HIV+

HIV-

HIV+

P-value*

FEV1/FVC

79.2 (4.83)

79.8 (5.44)

63.4 (6.75)

61.2 (7.95)

<0.01

FEV1

     

   Absolute (L)

2.93 (0.75)

2.80 (0.66)

2.36 (0.84)

1.97 (0.73)

<0.01

   % Predicted

95.9 (15.3)

95.0 (15.2)

73.8 (18.2)

66.4 (19.7)

<0.01

FVC

     

   Absolute (L)

3.71 (0.96)

3.53 (0.86)

3.69 (1.17)

3.17 (1.01)

<0.01

   % Predicted

97.5 (15.8)

96.2 (15.8)

92.3 (18.9)

86.1 (20.5)

<0.01

  1. *P-value represents test for overall difference across means. Values presented as mean (S.D.) OLD = Obstructive lung disease; HIV = human immunodeficiency virus; FEV1 = Forced expiratory volume in 1 sec; FVC = Forced vital capacity;
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us